Nome
Live Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone Cancer
Código
BoneOscopy - Project 101185141
Entidade Beneficiária
LIP - Laboratório de Instrumentação e Física Experimental de Partículas
Sumário do Projecto
BoneOscopy is a European Union’s Horizon EIC-Pathfinder Open project with the ambition to revolutionise the treatment landscape for bone cancer by establishing a new standard of care. Bone metastasis remains a severe health challenge, with traditional imaging methods often falling short. BoneOscopy seeks to fill this gap by enabling daily tumour monitoring during treatment. The project utilises spectroscopy analysis to assess bone density and calcium content without additional radiation exposure, providing precise treatment data for better decision-making. This approach has the potential to herald a paradigm shift in the treatment of metastatic bone cancer, offering a more personalised therapeutic approach. Bone metastasis presents a significant health challenge, often inadequately addressed by traditional imaging methods. BoneOscopy aims to bridge this gap by enabling daily monitoring of tumors during treatment. Utilising spectroscopy analysis, BoneOscopy assesses bone density and calcium content without additional radiation exposure, delivering personalised and precise data that support informed treatment decisions. This innovative approach holds the potential to revolutionise metastatic bone cancer treatment, introducing a new era of precision and personalisation in therapy.
Suporte sob
Other
Região de Intervenção
...
Financiamento
Custo total elegível
€ 3,069,321.00
Apoio financeiro da UE
Financiamento p/ LIP
€ 0.00
€ 550,045.00
Apoio financeiro público Nacional
€ 0.00
Datas
Aprovação
Início
2025-01-01
Fim
2029-12-31
Reconhecimentos
The BoneOscopy project has received funding from the European Union’s Horizon Europe research and innovation programme under the Grant Agreement N 101185141, and for the Swiss partner from the Swiss State Secretariat for Education, Research and Innovation (SERI). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Innovation Council. Neither the European Union nor the granting authority can be held responsible for them.